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ABSTRACT 
The innate immune system is activated in a number of degenerative and inflammatory retinal 
disorders such as age-related macular degeneration (AMD). Retinal microglia, choroidal 
macrophages, and recruited monocytes, collectively termed ‘retinal mononuclear phagocytes’, 
are critical determinants of ocular disease outcome. Many publications have described the 
presence of these cells in mouse models for retinal disease; however, only limited aspects of 
their behavior have been uncovered, and these have only been uncovered using a single 
detection method. The workflow presented here describes a comprehensive analysis strategy 
that allows characterization of retinal mononuclear phagocytes in vivo and in situ. We present 
standardized working steps for scanning laser ophthalmoscopy of microglia from MacGreen 
reporter mice (mice expressing the macrophage colony-stimulating factor receptor GFP 
transgene throughout the mononuclear phagocyte system), quantitative analysis of Iba1-
stained retinal sections and flat mounts, CD11b-based retinal flow cytometry, and qRTRT–
PCRPCRPCR analysis of key microglia markers. The protocol can be completed within 3 d, 
and we present data from retinas treated with laser-induced choroidal neovascularization 
(CNCNV), bright white-light exposure, and Fam161a-associated inherited retinal 
degeneration. The assays can be applied to any of the existing mouse models for retinal 
disorders and may be valuable for documenting immune responses in studies for 
immunomodulatory therapies. 
 
  
3 
 
INTRODUCTION 
Retinal glial cells are separated into macroglia and microglia. The two macroglial cell 
populations in the retina are Müller cells and astrocytes. Müller cells are essential for retinal 
physiology including neurotransmitter and metabolite homeostasis and support the blood-
retinal barrier1. Astrocytes are located to the nerve fibre layer where they shield ganglion cell 
axons and envelop blood vessels, thereby also contributing to the inner blood-retinal barrier2. 
Upon retinal damage, both cell types typically respond with reactive gliosis2. Microglia, the third 
glial cell type of the retina, belongs to the resident tissue macrophage population of the central 
nervous system3. 
In the healthy adult retina, microglia show a distinct ramified morphology and are exclusively 
located in the inner and outer plexiform layers4. Their somata are relatively static under 
physiological conditions and a regularly spaced cellular network spans the whole inner retina5. 
From these strategic positions microglia constantly scan the retina with their long protrusions, 
sensing disturbance in tissue homeostasis6. They can rapidly respond to retinal insults often 
associated with cellular migration to the sites of damage7. Concomitantly, the cells retract their 
protrusions and transform into amoeboid phagocytes that can produce a variety of neurotoxic 
inflammatory mediators including reactive oxygen species and cytokines8. Reactive microglia 
clear dying neurons but can also damage and phagocytose whole living photoreceptors in the 
diseased developing retina9,10. Under specific conditions of retinal lipid accumulation, 
intraretinal or subretinal microglia appear as lipid-bloated cell aggregates11,12. 
In addition to resident microglia, the mononuclear phagocyte population in the retinal area also 
includes local macrophages of the vasculature, the ciliary body, and choroid as well as 
infiltrating macrophages that differentiate from blood monocytes. The mononuclear 
phagocytes that infiltrate the subretinal space in conditions when the blood retinal barriers are 
compromised can be distinguished from resident microglia by different technological 
approaches. Studies that generated bone marrow chimeras with EGFP-transgenic mice and 
performed subsequent flow cytometry showed that perivascular macrophages expressed less 
F4/80, CD45, and Iba-1 compared with parenchymal microglia13. However, the use of bone 
marrow transplantation to generate GFP+ leukocyte chimeras is problematic as it necessitates 
total body irradiation which may alter microglia function and cranial sparing resulting in 
incomplete bone marrow engraftment. To better evaluate the extent of inflammatory 
monocytes in subretinal mononuclear phagocyte accumulation, we previously used a simpler 
method14. We permanently marked the circulating monocytes with repeated EdU injections, a 
traceable nucleotide that is integrated in the DNA of dividing cells, prior to and during light-
induced subretinal inflammation in Cx3cr1-/- mice. Three daily intraperitoneal injections were 
sufficient and necessary to mark the majority of the short lived circulating monocytes. The 
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number of subretinal EdU+ cells can then be compared in mice with and without clodronate-
liposome-induced monocyte depletion. Local EdU administration failed to mark subretinal cells, 
suggesting that ocular proliferation does not play a significant role in the light-induced 
accumulation of subretinal macrophages14. This technique can only be used for short-term 
experiments and is not adapted for the evaluation of chronic inflammation. To evaluate the 
participation of monocyte-derived cells versus microglia in a more definite and less invasive 
way, fate-mapping experiments with Cx3Cr1CreER mice and R26-YFP reporter mice were 
reported recently15,16. Tamoxifen treatment of the resulting Cx3Cr1CreER : R26-stop-YFP mice 
induces YFP expression in all Cx3cr1-expressing cells. Resident phagocytes including 
microglia express Cx3cr1 most strongly, along with a subset of monocytes. Due to their faster 
turnover rate, labeled monocytes are replaced by non-labeled cells once tamoxifen dissipates. 
In contrast, longer-lived microglia and macrophages retain the fluorescent label and 
consequently show YFP expression. Applying multicolor flow cytometry on retinas of this 
model, O´Koren et al. have shown that retinal microglia have a unique cell surface marker 
profile with low expression of CD45, CD11c, F4/80, and I-A/I-Elo that is also maintained in a 
light challenge paradigm16. The intravenous administration of fluorochrome-conjugated anti-
CD45 antibody then allowed exclusion of CD45+ circulating cells from retinal mononuclear 
phagocyte analyses16. These FACS-based methods could differentiate resident from infiltrating 
mononuclear phagocytes in whole eye, or in retinal single cell suspensions. Similarly, we have 
recently shown that resident mononuclear phagocytes play a key role in the mouse model of 
laser-induced choroidal neovascularization (CNV) that mimics the exudative form of age-
related macular degeneration (AMD)15. 
 
Development of the protocol 
Phagocytic murine retinal microglia have been traced by retro-grade labeling of ganglion cells 
with different dyes17, but more common now is in vivo imaging with GFP-expressing transgenic 
animals 18-21 and/or immunostaining with the marker ionized calcium binding adapter molecule 
1 (Iba1)22. The retinal fundus is optimal for non-invasive imaging and GFP-labeled or 
autofluorescent phagocytes can be visualized with a confocal scanning laser ophthalmoscope 
in the blue auto-fluorescence mode. This procedure is especially useful in conditions where 
GFP+ microglia accumulate at focal lesion areas around atrophic areas23 or close to 
experimental laser spots  18,21. Microglia can be directly imaged when they contain auto 
fluorescent endogenous lipids due to lipid storage disease11 or when they have ingested large 
amounts of lipofuscin granules related to retinal aging processes24.  
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We have previously compared F4/80 and Iba1 to visualize retinal microglia in retinal sections 
and flat mounts of retinoschisin-deficient mice, a model for human X-linked retinoschisis, and 
found that Iba1 is superior to F4/80 in both types of in situ methods25. In fact, most recent in 
situ analyses of ramified and reactive retinal microglia rely on Iba1 staining26-30 as the marker 
allows consistent and reliable staining of microglia somata and their processes in a broad 
spectrum of different activation phenotypes31-33. In general, a combined in situ analysis of 
retinal microglia using sections and flat mounts as presented in our protocol is recommended. 
This allows the counting of ramified and amoeboid mononuclear phagocytes and 
characterization of their morphology using a quantitative grid cross method32,34. 
In our previous work, we also have performed retinal microglia analysis using flow cytometry 
and gene expression profiling. We have learned that Iba1 is not optimal for FACS as it requires 
a longer intracellular staining procedure and leads to more nonspecific signals. However, 
CD11b (OX42), a broadly expressed integrin marker of mononuclear phagocytes is suitable to 
determine relative numbers in either total retinal cell homogenates32,35 or pre-sorted phagocyte 
populations36. 
Gene expression analyses for microglia markers either in total retinal RNA or in sorted cells is 
a very useful tool to determine their activation phenotype. We have previously characterized 
the macrophage/microglia WAP domain protein (AMWAP) as a regulator of pro-inflammatory 
response37,38. AMWAP transcription is rapidly induced in microglia from different retinal 
disease mouse models, including inherited photoreceptor dystrophies and different light 
challenge paradigms 7,32,33,39. Another good marker to detect microglia reactivity is CC-
chemokine ligand 2 (CCL2, alias monocyte chemoattractant protein 1, MCP-1), which has a 
key role in pro-inflammatory mononuclear phagocyte chemotaxis and migration in the 
retina14,40.  
 
Overview of the procedure 
The workflow of the analysis is illustrated in Figure 1 and contains three main steps: a) in vivo 
imaging via OCT analysis, b) histological and c) molecular analysis of retinal mononuclear 
phagocytes. The histological analysis comprises stainings of retinal cryo sections and flat 
mounts to analyze the cellular distribution and morphology from two different perspectives. 
Furthermore, flow cytometry and gene expression profiling help to describe the activation 
status of mononuclear phagocytes and their contribution to disease progression. The 
characterization strategy presented here includes common laboratory methods such as 
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fluorescence microscopy, flow cytometry and qRT-PCR but requires basic understanding of 
retinal anatomy and immunology. 
 
Applications of this method 
We have recently applied main parts of the protocol to fully characterize the protective role of 
mononuclear phagocyte interferon- signaling in the AMD-related mouse model of laser-
induced CNV15. Using conventional interferon-/-receptor knockout mice (IFNAR1-/-)41 and 
Cx3cr1CreER:Ifnar1fl/fl15 animals that allowed the tamoxifen-induced conditional depletion of Ifnar 
in resident mononuclear phagocytes only showed that interferon signaling in resident cells and 
not inflammatory monocytes play a key role in choroidal neovascularization in this setting. This 
protocol described here is now routinely established in the authors´ laboratories and can be 
principally applied to any project related to retinal disease that involves mononuclear 
phagocyte reactivity. Such models of ocular disease include all genetic mouse lines for retinal 
dystrophies and experimental models for uveitis, glaucoma, diabetic retinopathy, retinopathy 
of prematurity, AMD, and many others42-48. 
 
Comparison with other methods and limitations of the protocol 
The very few published protocols to specifically analyze retinal mononuclear phagocytes are 
limited to individual aspects related to their functional diversity. The in vivo responses of 
phagocytes has been documented in laser injury of the fundus using confocal scanning laser 
ophthalmoscope18 and ex vivo isolation of microglia and calcium imaging has been used to 
characterize their phagocytic phenotype49. Many more studies used marker staining in retinal 
sections and to a lesser extent flat mounts to describe the morphology and location of retinal 
microglia7,50.  
The general protocol presented here involves a complementary and step-wise procedure to 
cover as many important aspects of retinal mononuclear phagocyte biology as possible (Fig. 
1). The first step is imaging for in vivo investigation of retinal microglia and infiltrating immune 
cells in the healthy and diseased retina. The major advantage is that the technique is non-
invasive, which allows retinal phagocytes to be studied in living animals at repeated time points 
such as at different stages of disease. The disadvantage is that the technique can only be 
used in animals in which myeloid cells are fluorescein-tagged either by genetic engineering or 
in vivo labeling/staining. Moreover, the resolution of in vivo imaging is relatively low compared 
to in situ confocal microscopy. The next step is histology to detect microglia in retinal sections 
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and flat mounts using immunostaining with the marker Iba1. The analysis of sections is 
especially useful to describe the relative location of cells within the retinal layers and to 
determine the number of migrating cells in a semi-quantitative manner. A drawback is that the 
horizontal spacing and network of resident cells cannot be visualized properly. To overcome 
this limitation, the analysis of corresponding flat mounts, either from the second eye or from 
other animals in the same experimental group is recommended. Flat mount staining of the 
retina and the RPE/choroid with Iba1 allows to describe the relative horizontal position of 
microglia within the regularly spaced network, their accumulation in focal lesion areas and 
exact morphological description using a quantitative grid cross method. However, very severe 
or late stage degenerative retinal pathologies may limit flat mount analyses due to tissue 
atrophy. The next block in our analysis pipeline is based on flow cytometry and gene 
expression profiling as molecular methods. The advantage of FACS is that quantitative single 
cell protein expression data can be obtained. Here, we describe the use of CD11b as an 
exemplary marker that works well to detect most mononuclear phagocytes in the retina. In a 
slightly adapted protocol, multiple antibody markers can be used to differentiate resident 
phagocytes from infiltrating monocytes 16,35. Finally, we present gene expression profiling of 
total retinal transcripts for AMWAP and CCL2, two markers related to microglia activation. 
Clearly, the limitation here is that only two transcripts are quantified. However, the expression 
of both markers mirrors mononuclear phagocyte activation in a broad range of retinal disease 
models7. Given the relative small amount of RNA from retinal samples it is advised to focus on 
selected marker genes. A potential perspective of our protocol is to perform gene expression 
profiling in flow cytometry or magnetic-activated cell (MACS, Miltenyi Biotec) sorted 
mononuclear phagocyte populations.  
 
Experimental design 
Mouse models and in vivo imaging. We applied the laser-CNV model44 to C57BL/6J mice 
and transgenic MacGreen19 animals, where a macrophage colony-stimulating factor receptor 
GFP transgene is expressed throughout the mononuclear phagocyte system of the mouse 19. 
Adult 6-8 week old mice are most appropriate for laser-CNV induction. As the mouse strain 
seems to influence CNV severity, appropriate back-crossing and littermate controls are 
recommended51. Subsequent analyses of infrared images and blue auto-fluorescence images 
from the same animal allows correlation of the impact of the laser lesions with the location and 
recruitment of mononuclear phagocytes (Fig. 2).  
Cross sections. To reproduce consistent and reliable immunohistochemical stainings, we use 
cryo embedded tissue. Using this protocol, the embedded tissue is less dehydrated and the 
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antigens are better conserved compared to paraffin embedded tissue. This has a major impact 
on the staining quality and facilitates to display the distinct cell morphology (Fig. 3). 
Flat mounts. In this protocol we describe the flat mount analysis of the inner retina. This 
method allows the characterization of resident retinal microglia distribution and morphology. 
Depending on the disease model, RPE/choroidal flat mounts can allow quantification of cell 
migration and cell accumulation in the subretinal space. In the laser-CNV model, reactive 
mononuclear phagocytes are a heterogeneous cell population consisting of microglia, 
choroidal macrophages and invading blood derived cells (Fig. 4). 
Quantification of microglia morphology. Counting of ramified versus round-shaped 
amoeboid cells in images of mononuclear phagocyte stainings provides a rapid but rough 
estimation of microglia morphology. As this method is subjective it can be difficult to accurately 
distinguish single cells from each other and to judge their activation status. We therefore highly 
recommend combining this method with a complementary quantification method. In our hands, 
the grid cross analysis is the best tool to describe and compare ramified versus amoeboid cell 
shapes in different experimental groups (Fig. 4)15,34. 
Flow cytometry. To specifically detect mononuclear phagocytes in the retina we stained 
dissociated tissue with fluorescently-labeled anti-CD11b+ antibody (Fig. 5). Flow cytometry 
enables to accurately quantify the percentage of mononuclear phagocytes in the retina in a 
relatively short time. This allows comparing their abundance in a broad spectrum of disease 
conditions. We have established a very robust protocol using the surface integrin marker 
CD11b and found that staining of intracellular markers is in most cases not recommended. 
Such protocols for staining of intracellular markers require a further permeabilization step, 
which increases the duration of the assay, and often leads to increased nonspecific binding. 
For specific questions such as fate mapping of individual mononuclear cell populations, 
simultaneous expression of several cell surface markers can be determined by multi-color flow 
cytometry16. The gating strategy and the required staining controls are provided in 
Supplementary Fig. 1. 
Gene expression. Gene expression analysis presented in this protocol aims at measuring 
transcript levels of two microglia marker genes, AMWAP38 and CCL252, in the complete retina. 
In three different disease models, namely genetic deletion of the Retinitis Pigmentosa Protein 
Fam161a39, in the laser-CNV model and in the light damage paradigm, these two markers 
reliably detect microglia reactivity (Fig. 6). Depending on the project, expression profiles 
reflecting general retinal inflammation or markers influenced by oxidative stress and 
constituents of the complement system could be determined. Since the amount of total RNA 
pooled from two retinas of the same animal is relatively high, a broad spectrum of additional 
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markers and reference genes could be analyzed depending on the specific research aims. 
Marker profiling of FACS-isolated cells is also possible and the use of a CD11b-based sorting 
method has been successfully demonstrated for CX3CR1-GFP expressing microglia53. 
However, because of limited sample quantity, quantification of expression data may be more 
prone to error. 
MATERIALS 
REAGENTS 
General reagents 
 Mice on C57BL/6J or BALB/c background. ! CAUTION All animal experiments must comply with 
national laws and institutional regulations. In our experiments, ARVO (Association for Research in 
Vision and Ophthalmology) guidelines were followed. 
 Bovine Serum Albumin (BSA) (Sigma-Aldrich, cat. no. A9418) 
 1.5 ml vials (Sarstedt, cat. no. 72.690) 
 2 ml vials (Sarstedt, cat. no. 72.689) 
 15 ml Falcon tube (Sarstedt, cat. no. 62.554.502) 
 50 ml Falcon tube (Sarstedt, cat. no. 62.554.254) 
 Gloves (Braun, 9205926)  
 96-well plate (Sarstedt, cat. no. 82.1581.001) 
 30 µl pipette tips (Matrix, cat. no. 7432) 
 Pipette tips (Sarstedt, cat. no. 70.760.002) 
 Phosphate buffered saline (PBS) (Amaresco, cat. no. E404) 
 ß-Mercaptoethanol (Sigma-Aldrich, cat. no. M-7154)  
 Transfer pipette 3.5 ml (Sarstedt, cat.no. 86.1173) 
 
In vivo Imaging 
 0.9% (w/v) NaCl (Fresenius Kabi, cat. no. 06605514) 
 Ketavet (ketaminehydrochloride) (Pfizer Animal Health)  
 Rompun (Xylazinhydrochlorid) (Bayer HealthCare)  
 1 ml syringe (BD PlastipakTM) 
 30G needle (BD MicrolanceTM) 
 Phenylephrin 2.5% (w/v)  
 Tropicamid 0.5% (w/v) 
 Hylo-Vision® Gel sine (Omni Vision GmbH)  
 
Immunohistochemistry 
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 anti-Iba1 antibody (Wako, cat. no. 01-1074) ▲ CRITICAL Store in aliquots to avoid frequent 
thawing.  
 Alexa Flour 488 antibody (goat anti-rabbit) (Thermo Fisher, cat. no. A-11008)  
 Cover glasses 18x18mm (Th.Geyer GmbH) 
 Cryomoldes (Tissue-TEK®, cat. no. 4557) 
 4′,6-Diamidin-2-phenylindol (DAPI) (Invitrogen, cat. no. D1306) 
 Fluorescent Mounting Medium (Dako, cat. no. 53023)  
 Microtome Blades C35 TYPE (Feather) 
 Pink PAP Pen (Zytomed Systems, cat. no. ZUC064) 
 Paraformaldehyde (PFA) (Sigma-Aldrich, cat. no. P6148) ! CAUTION PFA is toxic and a potential 
carcinogen. It should be handled with care and discarded as hazardous waste. 
 Powdered milk (Roth, cat. no. T145.3) 
 Sodium azide (NaN3) (Roth, cat. no. 4221) ! CAUTION NaN3 is highly toxic and very dangerous for 
the environment. It should be handled with care and discarded as hazardous waste.  
 Sucrose (Merck, cat. no. 1.07651) 
 Superfrost® PLUS microscope slide (Fisher Scientific, cat. no. 12-550-15) 
 Triton X-100 (Sigma-Aldrich, cat. no. X100) 
 Tween-20 (Sigma-Aldrich, cat. no. P1379) 
 Tissue-Tek O.C.T. compound (Hartenstein)  
 
Flow cytometry 
 CD11b-APC antibody, Reactivity: mouse, human, Clone: M1/70.15.11.5 (isotype: rat IgG2b). 
(MACS Miltenyi Biotec, cat. no. 130-098-088) ▲ CRITICAL Store at 2-8 °C and protect from light. 
Contains stabilizer and 0.05% (w/v) sodium azide ! CAUTION sodium azide is highly toxic and very 
dangerous for the environment. It should be handled with care and discarded as hazardous waste.  
 Rat IgG2b isotype control antibody – APC, clone ES26-5E12.4 is specific for KLH (keyhole limpet 
hemocyanin). This protein is not expressed on mammalian cells. (MACS Miltenyi Biotec, cat. no. 
APC 130-102-664) ▲ CRITICAL Store at 2-8 °C and protect from light. Contains stabilizer and 
0.05% (w/v) sodium azide. Do not freeze. The expiration date is given by the manufacturer and 
usually indicated on the vial label. ! CAUTION sodium azide is highly toxic and very dangerous for 
the environment. It should be handled with care and discarded as hazardous waste.  
 FcR Blocking Reagent, mouse (MACS Miltenyi Biotec, cat. no. 130-092-575) ▲ CRITICAL Store at 
2-8 °C and protect from light. Contains stabilizer and 0.05% (w/v) sodium azide. Do not freeze. The 
expiration date is given by the manufacturer and usually indicated on the vial label. ! CAUTION 
sodium azide is highly toxic and very dangerous for the environment. It should be handled with 
care and discarded as hazardous waste.  
 DPBS Dulbecco’s Phosphate Buffered Saline with calcium and magnesium (Bio Whittaker, Lonza, 
cat. no. BE17-513F) 
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 Ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, cat. no. E9884) 
 FACS buffer: PBS, 2mM EDTA, 0.5% (w/v) BSA, pH 7,2 
 Viobility 405/452 TM Fixable Dye (MACS Miltenyi Biotec, cat. no. 130-110-205) CRITICAL Store dry 
and protect from light. Viobility 405/452 TM Fixable Dye can be excited by the violet 405 nm laser 
and has a peak excitation of 450 nm, that can be detected using a 450/50 band pass filter (equivalent 
to Pacific Blue®) 
 FluoroFix Buffer (Biolegend, cat. no. 422101, storage at at 2-8 °C) ! CAUTION The fixation buffer 
contains paraformaldehyde, which is toxic and mutagenic. 
 1.5ml micro tube (Sarstedt, cat. no. 72.690.001)  
 ß-Mercaptoethanol (Gibco 50mM, cat.no.31350010) ! CAUTION ß-Mercaptoethanol is toxic and 
dangerous for the environment. It should be handled with care and discarded as hazardous waste.  
 Neural Tissue Dissociation Kit- Postnatal neurons, (MACS Miltenyi Biotec, cat. no. 130-094-802, 
storage at 2-8 °C, protect from light) 
 5ml Polysterene Round – Bottom Tube with cell strainer (BD Falcon, 12x75mm, style 2262790, cat. 
No. 352235) 
▲ CRITICAL All reagents and equipment may be substituted with alternatives from other 
manufacturers.  
 
Gene expression 
 Adhesive qPCR seal (4titude, cat. no. 4ti-0560) 
 dNTP Mix, 10 mM each (Thermo Scientific, cat. no. R0132) 
 Dual-labeled probe (Roche Universal Probe Library, Roche) 
 Ethanol (AppliChem, cat. no. A3678) 
 FastStart Universal Probe Master (Roche, cat. no. 14943600) 
 Filter tips Biophere®  (Sarstedt, cat. no. 70.762.217 – 211) 
 NucleoSpin® RNA Mini Kit (Macherey-Nagel, cat. no. 740955) 
 PCR stripes (Biozym, cat. no. 711030) 
 384 PCR plate FrameStar®  (4titude, cat. no. 4ti-0384/c) 
 RevertAidTM RT Kit (Thermo Scientific, cat. no. K1691) 
 RevertAidTM M-MulLV (Thermo Scientific, cat. no. EPO441) 
 TaqMan Gene Expression Master Mix (Invitrogen Life Technologies) 
 Taq Polymerase (Qiagen, cat. no.  105476) 
▲ CRITICAL All reagents and equipment may be substituted with alternatives from other 
manufacturers.  
 
EQUIPMENT 
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 7900 HT Fast Real-Time PCR System (AB Applied Biosystems) 
 AdventurerTM Pro balance (Ohaus®)  
 ApoTome.2 (Zeiss) 
 AxioCam ICc 1 camera (Zeiss) 
 AxioCam MRm camera (Zeiss) 
 Centrifuge 5415 R (Eppendorf) 
 Centrifuge Mini Star (VWR International) 
 Cryostat CM3050 (Leica) 
 Explorer® Ex 124 balance (Ohaus®) 
 Imager.M2 microscop (Zeiss) 
 Heraeus Labofuge 400 R (Thermo Scientific) 
 HRA+OCT Spectralis (Heidelberg Engineering) 
 NanoDrop 2000 Spectrophotometer (Thermo Scientific) 
 See-saw rocker SSL4 (Stuart®) 
 Stainless steel bead, 5 mm diameter (Qiagen, cat. no. 69989) 
 TissueLyser LT (Qiagen, cat. no. 69980) 
 Vortex-genie® (Scientific IndustriesTM) 
 BD FACS Canto II 
 Thermomixer compact (Eppendorf) 
SOFTWARE 
 GraphPad PRISM 6 (GraphPad Software, Inc.) 
 Spectralis HRA+OCT Software (Heidelberg Engineering) 
 ImageJ (Wayne Rasband, NIH) 
 Office Suite (Microsoft Corporation) 
 RQ Manager 1.2.1 (Applied Biosystems) 
 SDS 2.3 (Applied Biosystems) 
 Flowjo software (Treestar Inc., Ashland, OR, USA)  
 
REAGENT SETUP 
 In vivo Imaging: Anesthesia solution Mix 3.2 ml 0.9% (w/v) NaCl with 0.6 ml Ketavet and 0.3 ml 
Rompun 2% (w/v). To anesthetize the mouse, inject 0.1 ml anesthesia solution per 20 g body weight. 
Use a 30G needle for intraperitoneal injection.  
▲ CRITICAL Prepare this solution fresh each time. 
 
 Immunohistochemistry: 4% (w/v) PFA Mix 4 mg paraformaldehyde in 100 ml 1x PBS. This 
solution can be stored at 4°C, protected from light for up to 6 months. ! CAUTION PFA is toxic and 
a potential carcinogen. It should be handled with care and discarded as hazardous waste.  
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 Immunohistochemistry: 30% Sucrose Mix 30 mg sucrose in 100 ml aqua dest. This solution can 
be stored a 4°C.  
 Immunohistochemistry: Antibody solution Mix 2 % (w/v) BSA, 0.2 % (w/v) NaN3, 0.1 % 
(volume/volume: v/v) Triton X-100 in 1x PBS. This solution can be stored at 4°C up to one year. ! 
CAUTION NaN3 is highly toxic. It should be handled with care and discarded as hazardous waste.  
 Immunohistochemistry: Blocking solution (BLOTTO) Mix 1 % (w/v) milk, 0.1 % (v/v) Tween 20 
in 1xPBS.  
▲ CRITICAL Prepare this solution fresh each time. 
 Immunohistochemistry: DAPI solution 0.1 µg in 1x PBS. This solution can be stored at 4°C, 
protected from light for up to one month.  
 Immunohistochemistry: Permeabilization buffer Mix 5 % (v/v) Triton X-100, 5 % (v/v) Tween 20 
in 1x PBS.  
▲ CRITICAL Prepare this solution fresh each time. 
 
Flow cytometry 
 Flow Cytometry: FACS buffer: Prepare a solution containing PBS, 2mM EDTA, 0.5% (w/v) bovine 
serum albumin (BSA), pH 7.2. This solution can be stored at 4°C up to one month.  ▲ CRITICAL 
Buffers containing Ca2+ or Mg2+ are not recommended for surface antigen staining and flow 
cytometry. 
 
Gene expression 
 Gene expression: qRT-PCR reaction mixture (10 µl per reaction) Mix 50ng cDNA, 1x TaqMan 
Gene Expression Master Mix (Invitrogen Life Technologies), 200 nM primers and 0.25 µl dual-
labeled probe (Roche Universal Probe Library, Roche). ▲ CRITICAL STEP Prepare this solution 
fresh each time. 
 
EQUIPMENT SETUP 
 HRA+OCT Spectralis (Heidelberg Engineering). ▲ CRITICAL To obtain a wide field view of the 
fundus use a 55° wide-angle lens (SPECTRALIS, No. 18868). GFP tagged microglia can also be 
imaged by the Micron IV system (Phoenix Research Labs), although the images are not as sharp 
due to lack of confocal functions. 
 
 BD FACS Canto II, if you use the fixable viability dye eFluor® 450 (e-Bioscience), you need a flow 
cytometer with a violet laser. 
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PROCEDURE 
In vivo retinal imaging ●TIMING 15 min per mouse 
1│ Anesthetize the mice by intraperitoneal injection with anesthesia solution at an appropriate dose (0.1 
ml anesthesia solution/ 20 g body weight). Anesthesia is effective for 30-40 minutes.  
▲ CRITICAL STEP This step must be performed by licensed and qualified individuals according to the 
animal welfare guidelines of the institutions.  
▲ CRITICAL STEP After 15-20 min the lens may get dull, so the funduscopic analyses should start 
immediately after anesthesia. 
? TROUBLESHOOTING 
 
2│Dilate the pupils of the mouse using 2.5% (w/v) Phenylephrin and 0.5% (w/v) Tropicamid.  
▲ CRITICAL STEP Wait for 5 min until the pupils are completely dilated. This is necessary to image 
the complete fundus. 
? TROUBLESHOOTING 
 
3│Analyze the location of laser spots and the distribution of mononuclear phagocytes by infrared images 
(IR) and blue auto-fluorescence (BAF) with the HRA+OCT Spectralis machine. 
▲ CRITICAL STEP To prevent the eye surface from desiccating constantly moisten the eyes with Hylo-
Vision® Gel sine. Dry eye surface influences the light beam and decreases the quality of funduscopic 
images. Remove the liquid drop before fundoscopy, because it also decreases the quality of the 
funduscopic images. 
▲ CRITICAL STEP To obtain high quality in vivo images make sure that the eye is positioned straight 
in front of the Spectralis lens.  
? TROUBLESHOOTING 
 
4│Start with infrared images (IR) where you can localize a laser spot (Fig. 2a, c) 
? TROUBLESHOOTING 
 
5│Switch to blue auto-fluorescence (BAF) to analyze the distribution of mononuclear phagocytes e.g. in 
MacGreen mice (Fig. 2b, d). 
▲ CRITICAL STEP The amount of auto-fluorescent signal can vary in different reporter mouse models.  
? TROUBLESHOOTING 
 
Immunohistochemistry • TIMING 4.5 h 
6│ Prepare 4% (w/v) PFA 
 
7│ Prepare Permeabilization buffer 
 
8│ Prepare BLOTTO 
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9│ Prepare antibody solution  
 
10│ Dilute primary antibody in antibody solution.   
 
11│ Euthanize mice by cervical dislocation and fixate enucleated eyes in 4% (w/v) PFA for no longer 
than 4 h at room temperature (RT ≙ 22°C). 
▲ CRITICAL STEP This step must be performed by licensed and qualified individuals according to the 
animal welfare guidelines in the state.  
? TROUBLESHOOTING 
 
12│Embed the eyes in optimal cutting temperature (OCT) compound for histological analysis of cryo 
sections (option A) or prepare eyes for flat mount analysis (option B) 
 
(A) Cryo sections • TIMING 2 d 
 
(i) To dehydrate the tissue, place the fixated eyes in 30% sucrose over night at room temperature.  
 
(ii) Embed eyes in cryomold® containers with OCT compound and use the gas phase of dry ice to freeze 
the embedded eye. 
▲ CRITICAL STEP label the orientation of the eyes. During the cutting procedure it is important to know 
how the lens is oriented. Make sure that the containers stand straight during freezing. 
 
■ PAUSE POINT embedded eyes can be stored until further processing at -80°C. 
 
(iii) Cut eyes in 12 µm sections in a cryostat. 
▲ CRITICAL STEP Before starting with cutting, be sure that the orientation of the eye is correct. The 
cutting direction is from the optic nerve towards the lens. This is necessary to avoid that the loose lens 
damages the retinal structure during sectioning.  
 
■ PAUSE POINT sections can be stored until further processing at -80°C. 
 
(iv) Encircle the respective retinal cross sections with liquid barrier (Pink PAP Pen, Zytomed Systems) 
and let it dry.  
▲ CRITICAL STEP Wait until the liquid barrier is completely dried, otherwise it may not be firmly 
attached to the slide and could detach which would interfere with staining. 
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(v) Rehydrate the cryo sections with 1x PBS for 15 min. Carefully remove the liquid using an exhaust 
pump. 
 
(vi)│ Incubate the cryo sections with Blotto for 30 min to prevent nonspecific binding. 
? TROUBLESHOOTING 
 
(vii) Carefully remove the liquid using an exhaust pump. 
 
(viii) Incubate cryo sections with 50-100 µl primary antibody per section (Iba1, Wako, dilution 1:500). 
Incubate for 4h at RT or overnight at 4°C  
 
(ix) Proceed the staining procedure by carefully remove liquid using an exhaust pump. 
 
(x) Wash cryo sections three times with 1−2 ml 1x PBS, after 5 min of incubation carefully remove the 
PBS using an exhaust pump. 
 
(xi) Incubate cryo sections with secondary antibody diluted in 1x PBS (goat anti-rabbit Alexa Flour 488, 
Thermo Scientific) for 1 h in the dark. 
 
(xii) Wash cryo sections three times with 1−2 ml 1x PBS, after 5 min of incubation carefully remove the 
PBS using an exhaust pump 
 
(xiii) Stain the nuclei with DAPI-solution (0.1 µg/ml in 1x PBS) for 10 min.  
 
(xiv) Wash cryo sections three times by adding 1−2 ml 1x PBS, after 5 min of incubation carefully 
remove the PBS using an exhaust pump 
 
(xv) Embed the fluorescently-labeled cryo sections in Dako and cover them with coverslips. 
▲ CRITICAL STEP Avoid forming air bubbles.  
 
■ PAUSE POINT Store the cryo sections in the dark at 2-8°C. It is recommended to analyze the 
fluorescently-labeled sections as soon as possible to avoid loss of fluorescence intensity. 
 
(xvi) Analyze microglia location and morphology using an Axioskop 2 Fluorescence microscope or a 
confocal microscope. 
The number of mononuclear phagocytes can be quantified by counting cells per section. Depending on 
the mouse model, mononuclear phagocytes can be located in different retinal layers such as the outer 
nuclear layer or the subretinal space (Fig. 3). 
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(B) Retinal flat mount analysis ●TIMING 3 d 
(i) Transfer the fixed eye ball in a cell culture dish with 1x PBS and perform all dissection steps while 
the eye is submerged to avoid drying of the tissue.  
 
(ii) Use Dumont #5 forceps to hold the eye at the optic nerve and spring scissors to remove the anterior 
part of the eye with a circular cut at the level of the ora serrata.  
 
(iii) Remove the lens, iris and optic nerve and carefully press with the forceps at the posterior part of the 
sclera to separate the retina from the retinal pigment epithelium and sclera. Keep both, the retinal and 
RPE/scleral flat mounts for staining, as subretinal MPs can stick to either side. 
 
(iv) Use spring scissors to cut the retina or the RPE/sclera in a four-leaf structure to avoid curling. Due 
to the natural shape of the retina, the tissue tends to curl up with the anterior retina inside (ganglion cell 
layer, inner plexiform and nuclear layer) and the posterior part (photoreceptor layer) outside. After 
flattening the tissue, the outer and inner retina can be distinguished by small pigmented particles of the 
RPE remaining at the retina. 
▲ CRITICAL STEP To avoid tissue damage do not transfer the retina with forceps. Use a cropped 
transfer pipet and transfer tissue in a drop of 1x PBS.  
? TROUBLESHOOTING 
 
(v) Incubate the flat mounts in the permeabilization solution on a see-saw rocker over night at 4°C.  
▲ CRITICAL STEP Keep each retina and RPE/sclera in single wells to avoid agglutination of the tissue.  
 
(vi) Incubate the flat mounts in BLOTTO on a see-saw rocker over night at 4°C or 4 h at room 
temperature to block nonspecific antigen-binding sites. 
 
(vii) Incubate flat mounts with the primary antibody (Iba1, Wako, dilution 1:500) over night at 4°C. 
 
(viii) Wash the tissue 3 times for at least 10 min in 1 ml 1x PBS on a see-saw rocker. 
▲ CRITICAL STEP To achieve sufficient washing make sure that the tissue floats freely in 1x PBS.  
 
(ix) Incubate the flat mounts with the secondary antibody diluted in 1x PBS (goat anti-rabbit Alexa Fluor 
488, Thermo Scientific) for at least 1 h in the dark. 
 
(x) Wash the tissue 3 times for at least 10 min in 1 ml 1x PBS on a see-saw rocker. 
▲ CRITICAL STEP To achieve sufficient washing make sure that the tissue floats freely in 1x PBS.  
 
(xi) Use a cropped transfer pipet to place the flat mount on a microscope slide (Superfrost® PLUS 
microscope slide, Fisher Scientific) with the vitreous side facing up and photoreceptor layer facing down. 
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(xii) Remove the remaining 1x PBS carefully with a tissue.  
 
(xiii) Embed flat mounts with Fluorescent Mounting Medium (Dako) and cover glasses no.1 (18x18 mm, 
Th.Geyer).  
▲ CRITICAL STEP To image neuroretinal phagocytes, mount the retinal tissue with the vitreous side 
facing up and the photoreceptor layer down. To image subretinal phagocytes at the photoreceptor outer 
segment layer, mount the retina with photoreceptor layer facing up and vitreous side down. To flat mount 
the RPE/sclera, extraocular tissues, such as conjunctiva, muscles, and optic nerve need to be 
completely removed.   
 
■ PAUSE POINT Store embedded object slides at 4°C until further processing.  
 
(xiv) To quantify microglial morphology examine the flat mount with a confocal microscope or a 
microscope equipped with an ApoTome device to depict the depth of the retinal tissue via optical 
sectioning (Fig. 4). 
? TROUBLESHOOTING 
 
(xv) Use ImageJ to define a region of 200-500 µm diameter around the laser spot and use the same 
region to quantify all images belonging to one experiment (Fig. 4c).  
 
(xvi) Count the number of round-shaped versus ramified mononuclear phagocytes (Fig. 4d).  
▲ CRITICAL STEP This is a relatively subjective method to quantify microglial activation. Furthermore, 
there may be stained fragments that cannot be clearly defined as single cells with distinct amoeboid or 
ramified morphology. It is therefore highly recommended to additionally perform the grid cross method 
to verify the findings from counting amoeboid versus ramified microglia. For some pathologies including 
models for diabetic retinopathy, it may be also important to differentiate between parenchymal and 
perivascular mononuclear phagocytes. 
 
(xvii) Use a grid system to determine the number of grid crossing points per cell34.  
Open the grid plugin of ImageJ to overlay the image with a grid (Fig. 4e, f). 
Count the number of grid crossing points per cell and calculate the mean grid crossed points per cell 
(Fig. 4g). 
▲ CRITICAL STEP The grid in the image depends on the image size and pixel dimensions. To ensure 
the data is comparable between groups, the image size and resolution from all samples should be 
consistent. 
 
Flow cytometry ●TIMING 7 h 
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13│ Prepare solutions for flow cytometry. To disscociate retinal tissue prepare enzyme mix 1 and 
enzyme mix 2 according to the guidelines of the Neural Tissue Dissociation Kit - Postnatal neurons 
(Table 1). 
 
Table 1: Enzyme mixes for tissue dissociation.  
 
▲ CRITICAL STEP For optimal results use a maximum of 400 mg of retinal tissue processed in 2 ml 
Enzyme mix for dissociation. 
▲ CRITICAL STEP Add -mercaptoethanol to Buffer Z at a final concentration of 0.067 mM. This 
solution will then be stable for 1 month at 4°C.  
▲ CRITICAL STEP Re-suspend the lyophilized powder in the vial labeled Enzyme A with 1 ml of Buffer 
A. Do not vortex. This solution should then be aliquoted and stored at –20 °C for later use. Pre-warm 
Buffer Z to room temperature before use. 
 
14│ Euthanize mice by cervical dislocation and collect retinas in 1x PBS buffer on ice. 
▲ CRITICAL STEP This step must be performed by licensed and qualified individuals according to the 
animal welfare guidelines in the state.  
▲ CRITICAL STEP If using retinal tissues, all steps must be performed at room temperature  
 
15│ Crop a plastic transfer pipette, so that the opening has a diameter of approximately 0.4 mm  
▲ CRITICAL STEP All tubes, cell strainers, and pipette tips should be rinsed with 1x PBS to avoid 
stickiness. 
 
16│ Transfer tissue into a 1.5 ml tube using a cropped plastic transfer pipette (0.4 mm) 
 
17│ Let tissue settle. Remove supernatant carefully. 
 
18│ Add 980 μl of enzyme mix 1 (Table 1) to the retinas. Agitate gently to ensure that tissue is detached 
from the bottom of the tube. 
 
19│ Incubate in a closed 1.5 ml tube for 15 min at 37 °C under slow, continuous shaking using a 
Thermomixer compact (Eppendorf). Invert the tubes every 5 min manually. 
 
 Enzyme mix 1 Enzyme mix 2 
Solution Enzyme P Buffer Z Buffer Y Enzyme A 
multiple 
retinas 
(<400mg) 
10 µl 1950 µl 30 µl 15 µl 
1-2 retinas 5 µl 975 µl 15 µl 7.5 µl 
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20│ Add 15 μl of enzyme mix 2 (Table 1). Dissociate tissue using a wet cropped plastic transfer pipette 
(0.4 mm) by pipetting the whole solution up and down 10 x very carefully.  
▲ CRITICAL STEP Use separate plastic transfer pipettes for each sample to avoid cross-
contamination. Avoid forming air bubbles.  
 
21│ Incubate for 10 min at 37 °C under slow, continuous shaking using a Thermomixer compact 
(Eppendorf).  
 
22│ Add 7.5 μL of enzyme mix 2 (Table 1). Dissociate tissue pieces using a wet cropped plastic transfer 
pipette (0.4 mm) by pipetting up and down 10 x very carefully. Dissociate tissue pieces further using a 
plastic transfer pipette, with its original opening, by pipetting approximately 1 ml up and down 40 x very 
carefully and slowly.  
▲ CRITICAL STEP Use separate plastic transfer pipettes for each sample to avoid cross-
contamination. Avoid forming air bubbles. Do not vortex.  
? TROUBLESHOOTING  
 
23│ Apply the cell suspension to a tube with 70 µm cell strainer. Carefully add 4 ml of 1x PBS and rinse 
all cells through the strainer. 
 
24│ Centrifuge at 130 x g for 10 min. Remove supernatant carefully 
 
25│ Resuspend cells carefully in 1x PBS to required volume by pipetting slowly up and down using a 1 
ml pipette tip. Do not vortex the cells. 
 
26│ Count cells (dilution 1:100) using a Neubauer chamber. Prepare cell suspension with desired 
concentration of nucleated cells. 
 
27│ Use Viobility 405/452 TM Fixable Dye (Miltenyi biotec) to exclude dead cells from analysis.  
▲ CRITICAL STEP For compensation: If a low number of dead cells is expected, then it is 
recommended to heat-kill cells (95°C for 5 min). Be aware that fixable viability dye also binds to a low 
amount to live cells (live cells can also have a shift in fluorescent intensity compared to unstained cells) 
if you analyze flow cytometry data. 
 
28│ Prepare cells in tubes. Wash cells 2 x with azide-free and serum/protein-free 1x PBS. Centrifuge 
cell suspension at 300xg for 10 min. Discard supernatant completely. ▲ CRITICAL STEP Make sure 
that you use 1x PBS free of azide, protein and any other amine-containing solution, because Viobility 
Fixable Dyes react with primary amine groups of proteins. 
 
29│ Resuspend up to 1x107 cells in 100µl azide-free and serum/protein-free 1x PBS. Add 1 μl of Viobility 
405/452 TM Fixable Dye. 
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30│ Mix well and incubate for 15 minutes in the dark at room temperature. ▲ CRITICAL STEP Note 
that higher temperatures or longer incubation time may lead to nonspecific binding. Working at low 
temperatures or on ice requires prolonged incubation time. 
 
31│ Wash cells 1-2 x with FACS buffer and proceed with further staining. 
 
32│ Centrifuge cell suspension at 300xg for 10 min at 4°C. Discard supernatant and proceed with Fc 
receptor (FcR) blocking and staining of surface antigens. 
 
33│ To increase specificity of antibody labeling block nonspecific binding to FC receptor (FcR). To block 
FcR resuspend up to 1x107 cells in 90 µl FACS buffer and add 10µl of FcR Blocking Reagent.  
 
34│ Incubate for 10 minutes at 2-8°C. 
 
35│ Proceed with staining of the surface antigen CD11b+. Add 10µl CD11b+ - APC antibody (up to 
1x107 cells in 100 µl FACS buffer containing FcR Blocking reagent , dilution:1:11) to the cell 
suspension . To examine nonspecific binding of the CD11b+ antibody, include an isotype control 
staining. Instead of using CD11b+ antibody, add 10 µl Rat IgG2b isotype control antibody conjugated 
to APC (up to 2x106 cells in 100 µl FACS buffer containing FcR Blocking reagent ). 
▲ CRITICAL STEP Cells should be stained prior to fixation if formaldehyde is used as a fixative.  
▲ CRITICAL STEP Buffers containing Ca2+ or Mg2+ are not recommended for surface antigen staining 
and flow cytometry. 
▲ CRITICAL STEP Note that higher temperatures or longer incubation time may lead to nonspecific 
binding. 
 
36│ Mix well and incubate for further 10 min in the dark at 2−8°C.  
▲ CRITICAL STEP Higher temperature or longer incubation may lead to nonspecific labelling. 
 
37│ Wash cells with FACS buffer (1-2 ml). Centrifuge cell suspension at 300×g for 10 min. Discard 
supernatant. 
 
38│ Resuspend cell pellet in a suitable amount of FACS buffer (100-200µl) for analysis or proceed with 
fixation (optional). Fixation of the cells is recommended, if the analysis cannot be performed immediately 
after the staining procedure.  
 
39│ Centrifuge cell suspension at 300xg for 10 min. Discard supernatant. For cell fixation, use 0.5 ml 
fixation buffer per tube (Fluoro Fix Buffer). Incubate cells in the dark for 30 min. ! CAUTION The fixation 
buffer contains paraformaldehyde, which is toxic and mutagenic. 
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40│ Wash cells by adding 1−2 ml of FACS buffer and centrifuge at 300×g for 10 min. Aspirate 
supernatant completely. 
 
41│ Resuspend cell pellet in a suitable amount of FACS buffer (100-200µl) for flow cytometry analysis.  
 
■ PAUSE POINT Store tube until analysis at 2-8°C in the dark covered with parafilm. Proceed with the 
analysis as soon as possible. 
 
 
42│ Quantify the number of CD11b+ cells by flow cytometry (e.g. using a FACS Canto II).  
  
43│ Gating strategy: Exclude doublets and dead cells. Perform frequency analysis of CD11b+ cells using 
the Flowjo software (Fig. 5a, b, c) (Supplementary Fig. 1 a). Include Isotype controls to examine 
nonspecific binding. Use heat-killed cells as positive control for live/dead cell analysis (Supplementary 
Fig. 1 b, c). Limitations: The relative percentage and number of cells per retina can be accurately 
quantified. However, information about location and morphology are missing. This protocol it is not 
suitable to differentiate between resident retinal immune and invading myeloid cells from the circulation 
such as monocytes or neutrophils. 
 
 
Gene expression ●TIMING 8 h 
 
44│ Prepare RNase-free lysis buffer (from the RNA extraction kit) on ice by adding ß-Mercaptoethanol.  
 
45│ Euthanize mice, by cervical dislocation and collect retinas in 1x PBS buffer on ice 
▲ CRITICAL STEP This step must be performed by licensed and qualified individuals according to the 
animal welfare guidelines in the state.  
 
46│ Pool both retinas of one animal and transfer to a 2.0 ml reaction tube with RNase-free lysis buffer 
and add stainless steel beads (5 mm diameter, Qiagen). 
 
47│ Homogenize retinal tissue for 1 min at 50/s using a TissueLyser LT homogenizer (Qiagen). 
 
48│ Centrifuge homogenized tissue for 5 min at full speed, discard pellet and proceed with the 
supernatant. 
▲ CRITICAL STEP If samples became hot during mechanical homogenization, precool buffers and 
steel beads and store samples on ice. 
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49│ Isolate total RNA with the NucleoSpin® RNA Mini Kit (Macherey-Nagel) according to the 
manufacturer’s protocol.  
 
50│ Dissolve RNA with 30 µl of RNase-free water.  
 
51│ Measure RNA concentration with a NanoDrop 2000 Spectrophotometer (Thermo Scientific). 
▲ CRITICAL STEP Always work under RNase-free conditions. 
▲ CRITICAL STEP Pool several retinas if poor RNA yield is obtained. 
? TROUBLESHOOTING 
 
■ PAUSE POINT Store RNA at -80°C until further use.  
 
52│ Reverse transcribe RNA into cDNA with the RevertAidTM RT Kit (Thermo Scientific) or comparable 
kit according to the manufacturer’s manual. 
 
■ PAUSE POINT Store cDNA at -20°C until further use. 
 
53│ Dilute cDNA with RNase-free water to a final concentration of 20 ng/µl. 
 
54│ Prepare 7.5 µl reaction mix per sample containing 5 µl 1x TaqMan Gene Expression Master Mix 
(Invitrogen Life Technologies), 1 µl forward primer (200 nM), 1 µl reverse primer (200 nM), 0.125 µl dual-
labeled probe (Roche Universal Probe Library, Roche) and 0.375 µl distilled water (Table 2).  
 
Table 2: Primers and Roche probes for quantitative real-time PCR.  
Gene  Direction Sequence Probe 
Atp5b forward  5´-GGCACAATGCAGGAAAGG-3´ #77 
 reverse  5´-TCAGCAGGCACATAGATAGCC-3´  
Amwap forward  5´-TTTGATCACTGTGGGGATGA-3´ #1 
 reverse  5´-ACACTTTCTGGTGAAGGCTTG-3´  
Ccl2 forward  5´-CATCCACGTGTTGGCTCA-3´ #62 
 reverse  5´-GATCATCTTGCTGGTGAATGAGT-3´  
 
55│ Pipette 2.5 µl cDNA into each well of a FrameStar® 384 PCR plate and add 7.5 µl reaction mix so 
that the final cDNA concentration is 50 ng per reaction well.  
 
56│ Centrifuge plate for 5 min with 900 rpm.  
■ PAUSE POINT Store PCR plates at 4°C in the dark until run is performed. 
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57│ Run the real time PCR reaction with following reaction parameters: 10 min at 95°C followed by 40 
cycles of 15 sec at 95°C melting and 1 min 60°C annealing/extension. 
 
58│ Analyze the results by using the ΔΔCt method for relative quantification (Fig. 6a-c)54.  
▲ CRITICAL STEP Prepare 10 % more reaction mix to compensate for pipetting loss. 
 
 
●TIMING 
Steps 1-5, Funduscopy: 15 min per mouse 
Steps 6-12, Immunohistochemistry - Reagent setup: 4.5 h 
Steps 12 A Cryo sections: 2 d 
Steps 12 B Flat mounts: 3 d 
Steps 13-43, Flow cytometry: 7 h 
Steps 44-58, Gene expression: 8 h 
 
? TROUBLESHOOTING 
Table 3: Troubleshooting.  
Step Problem Possible reason Solution 
 
1 
 
Dull lens 
 
 
Death of mice 
 
Mice are under anesthetic for 
too long.  
 
Overdose of anesthetic.  
 
 
Anesthetize animal shortly before in vivo 
analysis.  
 
Weigh animal before injection to calculate 
optimal dose. 
 
2 
 
 
 
 
 
3 
 
Insufficient insight in fundus 
 
 
 
 
 
Poor in vivo image quality 
 
 
Pupil is not entirely dilated.  
 
 
 
 
 
Light cannot enter the eye 
and/or reflection is not collected 
properly.  
 
 
Wait a few minutes until the Iris dilator muscle 
is completely relaxed. Make sure that the 
Phenylephrin/ Tropicamid mixture has not past 
passed its expiration date. 
 
 
Change the position of the animal in front of the 
objective. 
 
4,5 Blurry fundus insight Sclera is too dry.  Use artificial tear drops or 0.9% (w/v) NaCl to 
moisten sclera. 
 
11 
 
Nonspecific staining 
 
Antigen conformation has 
changed 
 
Reduce time of fixation  to preserve natural 
protein structures.  
 
 
12 A 
(vi) 
 
High background staining 
 
 
Insufficient washing or old 
BLOTTO solution.  
 
Extend washing time when background 
staining is too prominent. Prepare fresh 
BLOTTO solution each time right before use.  
 
12 B 
(iv) 
 
Irregular stained retina 
 
 
Tissue is curled up during 
staining procedure 
 
Cut the retina in a four-leaf structure before 
starting the staining protocol.  
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12 B 
(xiv) 
Insufficient image quality Objective quality, microscope 
equipment 
To define microglia distribution in the different 
retinal layers, imaging the flat mount in z-stacks 
is highly recommended. When using the 
Axioskop2 MOT Plus Apotome microscope 
(Carl Zeiss) it is recommended to use the Plan-
Apochromat objective 20x/0.8 M27 (No. 
420650-9901-000, Carl Zeiss) 
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Retina is poorly dissociated 
 
The diameter of the cropped 
transfer pipette is too big.  
 
Crop the transfer pipette at different areas to 
vary the diameter. Try to use different 
diameters and continue pipetting the tissue up  
and down. It may take some time until the 
tissue is completely dissociated; continue until 
you have a single cell suspension. 
 
 
51 
 
Low RNA quality 
 
Tissue sample has been stored 
to long.  
  
 
Process tissue as fast as possible and, if 
necessary, store tissue at -80°C.  
  
51 Low RNA quantity  RNA has been degraded Make sure you use RNase-free reagents and 
material.  
 
 
ANTICIPATED RESULTS 
Reactivity of mononuclear phagocytes is a general hallmark of the innate immune response occurring 
in various degenerative and inflammatory retinal disorders. In this protocol, we outline comprehensive 
methods to characterize the most important aspects of mononuclear phagocyte biology in the mouse 
retina. Fluorescently labelled microglia can be visualized in vivo with confocal scanning laser 
ophthalmoscopy (Fig. 2). The location and distribution of mononuclear phagocytes can be defined by 
counting Iba1- cells in retinal cryo sections as shown for a genetic model of retinal degeneration (Fig. 3 
a-d) and for a white light damage paradigm (Fig. 3 e-h). The overall cell morphology in the regularly 
spaced network is then characterized in retinal flat mounts stained with Iba1 (Fig. 4 a,b). The activation 
status of mononuclear cells in a laser lesion is described by counting the number of ramified (asterisks) 
versus amoeboid cells (circles) in a defined area (Fig. 4 c,d) and the cell morphology can be further 
verified by grid cross analysis (Fig. 4 e-g). The relative percentage of retinal mononuclear phagocytes 
can be determined by flow cytometry gating on CD11b+ live cells (Fig. 5 a-d). The expected relative 
percentage of live cells and CD11b+ cells in the healthy retina should be more than 70% and less than 
1%, respectively (Fig. 5 a,b). In the light damage model, the number of live cells stays approximately 
the same, whereas the population of mononuclear phagocytes increases up to 3.4% (Fig. 5 a-d). The 
percentage of mononuclear phagocytes varies between disease models and time points. The gating 
strategy shows how to precisely analyze the amount of CD11b+ cells after excluding doublets and dead 
cells (Supplementary Fig. 1 a). Additionally, the staining controls for flow cytometry demonstrate a 
specific signal of CD11b-APC antibody compared to isotype and FMO controls (Supplementary Fig. 1 
b,c).The magnitude of mononuclear phagocyte activation can be measured with quantitative RT-PCR 
analysis of the markers AMWAP and CCL2, applied here to retinas with Fam161a mutation39, in the 
laser-CNV model44, and in a white light damage model32, 33 (Fig. 6 a-c).  
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Figure legends 
Figure 1. Diagram illustrating the comprehensive microglia characterization procedure. 
The protocol includes in vivo funduscopy as first step followed by in situ analyses including 
immunohistochemistry, flow cytometry, and gene expression. 
 
Figure 2. Funduscopy of C57BL6/J mice (a, b) and MacGreen mice (c, d) mice after laser-
treatment of the retina imaging infrared (IR) and blue autofluorescence (BAF) with an excitation 
wavelength of 488 nm. The lesion area is visible in both mouse lines in the IR channel (a,c), 
whereas EGFP-labeled microglia are only detectable in MacGreen reporter mice (d; BAF 
channel). White dashed circles highlight the area of the laser spot. For this method 8 to 10 
weeks old female mice have been used and the experiment was approved by the governmental 
body responsible for animal welfare in the state of North Rhine-Westphalia, Germany with the 
permission number Az 84-02-04-2015-A039 and followed the ARRIVE guidelines55.  
 
Figure 3. Immunohistochemical analyses of microglia in retinal cross sections. (a) Iba1-
immunolabeled and DAPI counterstained cryo section of a healthy C57BL6/J control mouse 
retina shows ramified microglia cells located in the outer plexiform layer (OPL) and inner 
plexifirm layer (IPL). (b) Image of a Fam161aGT/GT mouse retina at an early postnatal time point 
shows microglia starting to infiltrate into the degenerating outer nuclear layer (ONL). (c) In a 
later stage of degeneration, amoeboid reactive microglia accumulate in the OPL and subretinal 
space. (d) Quantification of retinal microglia distribution by counting the number of Iba1+ cells 
in the ONL and subretinal space per each section. (n = 1 exemplary image). (e) Ramified 
microglia cells in untreated Balb/c control mouse. (f) Amoeboid reactive microglia migrate into 
the ONL one day after light-exposure. (g) Iba1+ cells are found into the subretinal space four 
days post light-damage. (n = 1 exemplary image). (h) Quantification of retinal microglia 
distribution by counting the number of Iba1+ cells in the ONL and subretinal space per each 
section. For the experiments male and female mice with an age between 4 and 12 weeks have 
been used and the experiments were approved by the governmental body responsible for 
animal welfare in the state of North Rhine-Westphalia, Germany with the permission numbers 
Az 84-02.05.20.12.158 and Az 84-02-04-2015-A039 and followed the ARRIVE guidelines55. 
 
Figure 4. Immunohistochemical analyses of microglia in retinal flat mounts. (a) 
C57BL6/J control mouse retina shows a network of ramified Iba1+ microglia in the plexiform 
layers. (b) The network is lost and amoeboid cells replace the ramified cells in degenerating 
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Fam161aGT/GT mouse retinas. (c) Amoeboid (circles) and ramified (asterisks) microglia 
accumulate in the lesion of the laser-CNV model. (d) Counting of ramified and amoeboid-
shaped microglia cells in a laser lesion. (n = 1 exemplary image). (e-g) Grid cross analysis to 
determine ramified (e) and amoeboid (f) cell morphology by counting the number of grid 
crossing points per cell. Bars show mean ± SD (n = 2-3 cells) (g). For the experiments male 
and female mice with an age between 8 and 12 weeks have been used and the experiments 
were approved by the governmental body responsible for animal welfare in the state of North 
Rhine-Westphalia, Germany with the permission numbers Az 84-02.05.20.12.158 and Az 84-
02-04-2014-A466 and followed the ARRIVE guidelines55. 
 
Figure 5. Flow cytometry analysis of retinal microglia. (a, b, top images) Flow cytometry 
to determine the percentage of living cells after retinal dissociation and staining. Only living, 
single cells are included in the further analysis of CD11b+ cells. (a, b bottom images) CD11b+ 
staining shows a low percentage of mononuclear phagocytes in the retina of a healthy control 
mouse. (a, bottom image) The percentage of CD11b+ cells increases significantly in retinas 
four days after light exposure (b, bottom image). The graph shows the percentage of CD11b+ 
cells per 500 000 analyzed cells. Mice exposed to bright white light show a significant higher 
percentage of CD11b+ cells. Data show mean ± SD **p < 0.0074 (c) The graph shows the 
number of CD11b+ cells per 500 000 analyzed cells. Mice exposed to bright white light show a 
significant higher number of CD11b+ cells. Data show mean ± SD **p < 0.008 (d). Flow 
cytometry data were analyzed using an unpaired Student’s t-test. (control n=5, light-damage 
n=5), one data point indicates the percentage or number of CD11b+ cells from both retinas of 
one individual mouse, respectively. Male Balb/c mice with an age between 16 and 20 weeks 
were used for flow cytometry analysis. The use of mice in this experiment was approved by 
the governmental body responsible for animal welfare in the state of North Rhine-Westphalia, 
Germany with the permission number Az 84-02-04-2015-A039 and followed the ARRIVE 
guidelines55. 
 
Figure 6. RT-PCR analyses of representative microglia activation marker genes. 
Activated microglia whey acidic protein (AMWAP) and CC-chemokine ligand 2 (CCL2) are 
reliable marker genes that reflect microglia reactivity in the Fam161aGT/GT degeneration model 
(a), in experimental laser-coagulation (b) and in the light-damage model of retinal degeneration 
(c). Data show mean ± SD (genetic model: n = 3-6, laser-CNV model: n = 3-4, light-damage 
model: n = 8-15 , samples measured in duplicates). The data were analyzed used the Student’s 
t-test (*p > 0.01, **p > 0.001, ***p > 0.0001). For the experiments male and female Balb/cJ, 
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C57BL6/J or Fam161GT/GT mice with an age between 8 and 12 weeks were used and the 
experiments were approved by the governmental body responsible for animal welfare in the 
state of North Rhine-Westphalia, Germany with the permission numbers Az 84-
02.05.20.12.158, Az 84-02-04-2014-A466 and Az 84-02-04-2015-A039 and followed the 
ARRIVE guidelines55. 
 
Supplementary Figure 1. Gating Strategy and staining controls for flow cytometry 
analysis. Representative FACS plots of a healthy control (a). Doublets and dead cells were 
excluded from analysis by determination of a single and a live gate. Afterwards the amount of 
CD11b+ cells can be analyzed (a). To determine a live gate, it is necessary to include an 
unstained control and heat-killed, ViobilityTM fixable dye stained control (b). To exclude 
nonspecific labeling of the CD11b+ antibody and to determine the CD11b+ gate, it is necessary 
to include Fluorescence minus one (FMO) controls without CD11b+ (FMO sample is labeled 
with FcR blocking reagent and ViobilityTM fixable dye) and isotype controls (c). (n=1 
representative image). Male Balb/c mice with an age between 16 and 20 weeks were used for 
flow cytometry analysis. The use of mice in this experiment was approved by the governmental 
body responsible for animal welfare in the state of North Rhine-Westphalia, Germany with the 
permission numbers Az 84-02.05.20.12.158, Az 84-02-04-2014-A466 and Az 84-02-04-2015-
A039 and followed the ARRIVE guidelines55. 
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Figure 1: Diagram illustrating the comprehensive microglia characterization procedure. 
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Figure 2: Retinal in vivo imaging of mice. 
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Figure 3: Immunohistochemical analyses of microglia in retinal cross‐sections. 
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  Figure 4: Immunohistochemical analyses of microglia in retinal flat mounts. 
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  Figure 5: Flow cytometry analysis of retinal microglia from control mice and animals after 
light damage. 
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Figure 6: Real‐time RT‐PCR analyses of representative microglia activation marker genes. 
